Jeffrey L Saver Selected Research

Thrombolytic Therapy

1/2022	Achieving More Rapid Door-to-Needle Times and Improved Outcomes in Acute Ischemic Stroke in a Nationwide Quality Improvement Intervention.
12/2020	Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries.
1/2020	Paramedic Global Impression of Change During Prehospital Evaluation and Transport for Acute Stroke.
1/2020	Is Door-to-Needle Time Reduced for Emergency Medical Services Transported Stroke Patients Routed Directly to the Computed Tomography Scanner on Emergency Department Arrival?
1/2019	An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial.
1/2017	Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population.
1/2016	Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients ≥90 Years of Age.
2/2015	Response to letter regarding article, "defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the national institute of neurological disorders and stroke tissue-type plasminogen activator trials".
1/2015	DWI Lesion Patterns Predict Outcome in Stroke Patients with Thrombolysis.
1/2015	Initial body temperature in ischemic stroke: nonpotentiation of tissue-type plasminogen activator benefit and inverse association with severity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey L Saver Research Topics

Disease

275	Stroke (Strokes) 12/2022 - 06/2003
224	Ischemic Stroke 03/2022 - 01/2002
35	Infarction (Infarctions) 01/2022 - 01/2005
23	Brain Ischemia (Cerebral Ischemia) 01/2022 - 12/2004
18	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 09/2012
17	Cerebral Hemorrhage 10/2021 - 01/2002
17	Hemorrhage 12/2020 - 09/2004
16	Atrial Fibrillation 01/2022 - 09/2004
16	Transient Ischemic Attack 10/2021 - 12/2004
13	Cerebral Infarction 01/2022 - 01/2005
10	Hypertension (High Blood Pressure) 01/2022 - 09/2005
9	Ischemia 10/2021 - 01/2003
8	Myocardial Infarction 12/2021 - 11/2008
8	Diabetes Mellitus 01/2020 - 09/2004
7	Hemorrhagic Stroke 01/2022 - 01/2008
7	Patent Foramen Ovale 12/2018 - 11/2008
6	Pathologic Constriction (Stenosis) 01/2021 - 09/2004
6	Heart Failure 12/2020 - 11/2010
6	Neurologic Manifestations (Neurological Manifestations) 11/2020 - 01/2008
6	Thrombosis (Thrombus) 06/2014 - 11/2003
5	Coronary Disease (Coronary Heart Disease) 12/2021 - 11/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 11/2010
5	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 07/2021 - 01/2012
5	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 08/2019 - 11/2007
5	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2017 - 12/2002
4	Hematoma 01/2022 - 02/2012
4	Brain Edema (Cerebral Edema) 01/2022 - 09/2013
4	Edema (Dropsy) 11/2021 - 01/2018
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 12/2004
3	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2009
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2021 - 12/2010
3	Ganglion Cysts (Ganglion) 10/2020 - 01/2019
3	Hyperglycemia 11/2018 - 01/2016
3	Venous Thrombosis (Deep-Vein Thrombosis) 10/2018 - 09/2013
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Epilepsy (Aura) 01/2022 - 11/2005
2	Migraine Disorders (Migraine) 01/2022 - 11/2005
2	Moyamoya Disease (Moya-Moya Disease) 01/2021 - 02/2019
2	Renal Insufficiency (Renal Failure) 01/2020 - 11/2014
2	Atherosclerosis 01/2020 - 01/2008
2	Embolic Stroke 01/2019 - 01/2014

Drug/Important Bio-Agent (IBA)

69	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2022 - 06/2003
24	MagnesiumIBA 01/2022 - 05/2004
18	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 05/2007
17	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2020 - 11/2006
15	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2005
10	Neuroprotective AgentsIBA 01/2022 - 01/2003
9	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 09/2004
8	AnticoagulantsIBA 01/2022 - 09/2004
8	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2022 - 05/2004
8	Cytidine Triphosphate (CTP)IBA 10/2021 - 01/2017
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2007
8	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 09/2005
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 10/2007
6	LipidsIBA 10/2021 - 01/2005
6	Indicators and Reagents (Reagents)IBA 01/2020 - 11/2003
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 09/2012
5	Clopidogrel (Plavix)FDA Link 12/2018 - 06/2011
5	HomocysteineIBA 12/2012 - 07/2008
5	CholesterolIBA 10/2010 - 01/2005
4	antineoplaston A10 (A 10)IBA 12/2021 - 01/2012
4	Tenecteplase FDA Link 01/2021 - 10/2018
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2020 - 01/2008
4	salicylhydroxamic acid (SHAM)IBA 10/2020 - 01/2019
3	Vitamin K FDA Link 01/2022 - 01/2018
3	Heparin (Liquaemin)FDA LinkGeneric 01/2020 - 09/2013
3	HDL LipoproteinsIBA 01/2020 - 09/2006
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018 - 06/2010
3	Pioglitazone (Actos)FDA Link 01/2017 - 01/2017
3	Pharmaceutical PreparationsIBA 02/2015 - 01/2003
3	Retinaldehyde (Retinal)IBA 01/2013 - 11/2008
3	HDL CholesterolIBA 08/2011 - 09/2006
3	Complement System Proteins (Complement)IBA 07/2010 - 09/2007
2	VaccinesIBA 01/2022 - 01/2009
2	Proprotein Convertase 9IBA 12/2021 - 01/2020
2	evolocumabIBA 12/2021 - 01/2020
2	MicroRNAs (MicroRNA)IBA 07/2021 - 12/2019
2	Biological ProductsIBA 07/2021 - 08/2011
2	Cilostazol (Pletal)FDA LinkGeneric 01/2021 - 01/2021
2	Dabigatran FDA Link 12/2020 - 01/2019
2	RivaroxabanIBA 12/2020 - 01/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2020 - 01/2016
2	Vasodilator Agents (Vasodilators)IBA 11/2019 - 10/2019
2	Nitroglycerin (Dynamite)FDA LinkGeneric 11/2019 - 01/2016

Therapy/Procedure

185	Therapeutics 12/2022 - 12/2002
96	Thrombectomy 10/2022 - 10/2009
26	Stents 11/2021 - 01/2012
22	Thrombolytic Therapy 01/2022 - 01/2002
10	Embolectomy 10/2018 - 12/2004
9	Time-to-Treatment 01/2020 - 11/2011
7	Catheters 01/2020 - 11/2003
7	Secondary Prevention 10/2018 - 12/2004
6	Contraindications 08/2019 - 01/2002
6	Length of Stay 01/2019 - 09/2006
5	Treatment Delay 12/2017 - 04/2014
3	Punctures 06/2021 - 01/2019
3	Carotid Endarterectomy 01/2014 - 09/2004
2	Aftercare (After-Treatment) 02/2022 - 08/2014
2	Cerebral Revascularization 12/2021 - 01/2013
2	General Anesthesia 01/2020 - 01/2020